Five strains of a hitherto unknown Actinomyces-like bacterium were isolated from human clinical sources, including blood cultures. Biochemical and chemotaxonomic characterization indicated that the strains were distinct from previously described Actinomyces and Arcanobacterium species. A comparative 16s rRNA gene sequence analysis demonstrated that the undescribed strains constitute a new subline within the ActinomycesArcanobacterium species complex. The closest known relative of the isolates was found to be Actinomyces suis, although a 16s rRNA sequence divergence value of approximately 6% clearly demonstrated that the unknown bacterium represents a distinct species. Based on the results of the present and earlier phylogenetic investigations, it is proposed that Actinomyces suis should be reclassified in a new genus, the genus Actinobaculum, as Actinobaculum suis comb, nov. In addition, a new species, Actinobaculum schualii, is proposed for the Actinomyces-like bacterium from human sources. The type strain of Actinobaculum schuulii is CCUG 27420.
gel electrophoresis (PAGE) of whole-cell proteins and cellular fatty acid (CFA) analysis, the strains were grown on 5% horse blood agar (Columbia base) at 37°C in 5% CO,. The PAGE analysis was performed as described previously (8) . For densitometric analysis, normalization, and interpretation of protein patterns a Pharmacia LKB-Ultro Scan XL instrument with Gel Scan XL software (Pharmacia, Uppsala, Sweden) and the Gelcornpar GCW 3.0 software package (Applied Maths, Kortrijk, Belgium) were used. CFA analyses were conducted by preparing fatty acid methyl esters and analyzing them by highresolution capillary gas chromatography with a model 5890A instrument (Hewlett-Packard, Avondale, Pa.) as described previously (12) . A cell wall murein analysis was carried out by using the methods of Schleifer and Kandler (11) except that thin-layer chromatography on cellulose sheets (Merck, Darmstadt, Germany) was used instead of paper chromatography. The phylogenetic analysis performed was a comparative 16s rRNA gene sequence analysis. A large fragment of the 16s rRNA gene (corresponding to positions 30 to 1521 of the Escherichia coli 16s rRNA gene) was amplified by PCR by using conserved primers close to the 3' and 5' ends of the gene.
The PCR products were purified by using a Prep-A-Gene kit (Bio-Rad, Hercules, Calif.) according to the manufacturer's instructions and were directly sequenced by using a Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems, Foster City, Calif.) and an automatic DNA sequencer (model 373A; Applied Biosystems). The closest known relatives of the new isolates were determined by performing a database search with the program FASTA of the Genetics Computer Group package (1) . The sequences of these organisms and those of other known related strains were retrieved from the EMBL and GenBank data libraries and were aligned with the newly determined sequences by using the program PILEUP (1). The resulting multiple-sequence alignment was corrected manually, and approximately 100 bases at the 5' end of the rRNA were omitted from further analyses because of alignment ambiguities. A distance matrix was calculated by Similarity dendrogram based on whole-cell protein patterns of Actinobaculum schaalii sp. nov. and related species. Levels of correlation were expressed as percentages of similarity for convenience.
using the programs PRETTY (1) and DNADIST (using the Kimura-2 correction parameter) (2) . A phylogenetic tree was constructed by the neighbor-joining method with the program NEIGHBOR (2) . The stability of the groups was estimated by performing a bootstrap analysis (500 replications) with the programs DNABOOT, DNADIST, NEIGHBOR, and CON-SENSE (2) .
The five human clinical isolates were gram-positive, nonmotile, non-spore-forming, non-acid-fast, straight to curved rods. Some cells exhibited branching. The strains were catalase negative and facultatively anaerobic. Acetate (the major component) and small amounts of succinate were produced as end products of metabolism in PYG broth. Relatively few sugars (viz., glucose, maltose, ribose, and D-xylose) were fermented. Some of the strains fermented L-arabinose, mannose, starch, sucrose, and trehalose. All of the isolates hydrolyzed hippurate, but alkaline phosphatase, arginine dihydrolase, m-galactosidase, P-galactosidase, P-glucuronidase, f3-mannosidase, gelatinase, and urease activities were not detected. None of the strains reduced nitrate to nitrite. The analysis of the CFA contents of the strains revealed that Cl0:, (1.5 ? 0.2% of the total CFA), C,,., (1.8 ? 0.3%), C,,,, (7.7 IT l%), C16:lw9c C18:lw9c (34.8 ? l%), C18:, (14.4 2 0.9%), and C18:2w6,9c (6.6 ? 1.2%) were the major acids. The cellular morphology, biochemical, and CFA characteristics of the unidentified clinical isolates resembled those of species of the genus Actinomyces and related taxa. The cell wall murein composition of strain CCUG 27420T was examined, and the cell wall murein type was found to be type Ma (L-LYS-L-LYS-D-G~U). The same murein type is found in Actinomyces neuii and Arcanobacterium huemolyticum, and this fact reinforces the affinity of the new clinical isolates with the Actinomyces-Arcanobacterium complex of species. The whole-cell protein profiles of the five unknown strains were determined by sodium dodecyl sulfate-PAGE. A dendrogram derived from a numerical analysis of the protein patterns is shown in Fig. 1 
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FIG. 2.
Unrooted tree showing the phylogenetic relationships of Actinobaculum schaalii sp. nov., members of the genus Actinomyces, and some other taxa. The tree, which was constructed by using the neighbor-joining method, was based on a comparison of approximately 1,320 nucleotides. Bootstrap values, expressed as percentages of 500 replications, are indicated at branch points.
together and formed a distinct branch. These data demonstrate that the unknown strains represent a phenotypically relatively homogeneous group and that they are distinct from all of the Actinomyces and Arcanobacterium spp. examined. To establish the phylogenetic affinities of the clinical isolates, the 16s rRNA genes of four strains were amplified by PCR and sequenced.
The sequences determined each consisted of > 1,400 nucleotides. A comparative sequence analysis showed that the four strains were genealogically homogeneous, exhibiting 99.7 to 100% 16s rRNA similarity. Sequence searches of the EMBL and GenBank libraries revealed that the newly determined sequences were most closely related to sequences of species belonging to the genera Actinomyces and Arcanobacterium. The sequence of strain CCUG 27420T was subjected to a painvise analysis with the sequences of Actinomyces and Arcanobacterium spp. and some other close relatives, and derived evolutionary distances were used to determine phylogenetic relationships. A tree depicting the phylogenetic affinities of strain CCUG 27420T is shown in Fig. 2 , and the levels of sequence similarity of this strain with Actinomyces and Arcanobacterium spp. are shown in Table 1 . The unidentified bacterium formed a distinct subline and displayed a relatively close affinity (approximately 94% 16s RNA sequence similarity) with Actinomyces suis. Bootstrap resampling revealed that the association between the unknown bacterium and Actinomyces suis was statistically significant (bootstrap value, 100%). The next closest relatives of the unknown bacterium were Arcanobacterium spp., which exhibited approximately 91 to 92% 16s rRNA sequence similarity. Other Actinomyces spp. displayed substantially lower levels of relatedness (generally <90% sequence similarity) ( Table 1) .
The results of both biochemical and whole-cell protein PAGE analyses showed that the five new clinical strains represent a homogeneous group of organisms and constitute a new species. Phylogenetically, the unknown bacterium forms a distinct subline within the Actinomyces-Arcanobacterium group of species (see reference 7) and exhibits a statistically significant relationship with Actinomyces suis, an organism associated with cystitis and pyelonephritis in pigs (13) . The affinity between the new unidentified human bacterium and Actinomyces suis was also evident from the whole-cell protein profile analysis results. Levels of 16s rRNA sequence divergence of >6% between the unidentified new strains and Actinomyces suis, however, clearly demonstrated that the bacterium from humans represents a previously unrecognized species. Although the novel bacterium phylogenetically resembles Actinomyces suis, it can be readily distinguished from the latter taxon by its production of acid from glucose and D-xylose, by its lack of production of acid from glycogen, and by its lack of production of P-glucuronidase and urease. The unknown new bacterium also differs from Actinomyces suis in its cell wall murein structure. Based on its phenotypic and phylogenetic distinctiveness, the unidentified new bacterium from humans clearly merits a new species. The generic assignment of this bacterium is, however, problematic. It has long been recognized that the genus Actinomyces is phenotypically very diverse (9, 10). Furthermore, recent comparative 16s rRNA sequencing studies (7) have demonstrated that the genus Actinomyces is not monophyletic and that members of several validated non-Actinomyces genera (e.g., the genera Arcanobacterium and Mobiluncus) are intermixed with Actinomyces species. The genus Actinomyces is clearly in urgent need of taxonomic revision, with several species groups and lineages representing the nuclei of new genera. As pointed out by Pascual et al. (7), Actinomyces suis is one such organism. This species displays approximately 10 to 14% 16s rRNA sequence divergence with the Actinomyces bovis cluster of species (sensu Pascual et al. [ 7 ] ) and exhibits a somewhat closer affinity with Arcanobacterium species (approximately 8 to 11% sequence divergence). Both sequence divergence and tree topology considerations clearly demonstrated that Actinomyces suis warrants a new genus. In the present study the unknown new bacterium from clinical sources exhibited a close (approximately 6% sequence divergence) and statistically significant (bootstrap value, 100%) phylogenetic association with Actinomyces suis. Therefore, based on the results of the previous study ( 7 ) and this study, we propose that Actinomyces suis and the unknown new bacterium from humans should be classified in a new genus, the genus Actinobaculum, as Actinobaculum suis comb. nov. and Actinobaculum schaalii sp. nov., respectively. Characteristics which distinguish Actinobaculum suis and Actinobaculum schaalii from each other and from related Actinomyces and Arcanobacterium species are shown in Table 2 . Description of Actinobaculum gen. nov. Actinobaculum (Ac-.ti.no.ba'cu.lum. Gr. n. actis, actinis, ray; L. neut. n. baculum, rod, stick; M. L. neut. n. Actinobaculum, ray stick). On blood agar cells are straight to slightly curved rods, some of which exhibit branching. Hemolysis is not observed. Cells are gram positive, not acid fast, and nonmotile and do not form spores. Anaerobic or facultatively anaerobic and catalase negative. Acid may or may not be produced from glucose. Acid is produced from maltose but is not produced from lactose, mannitol, melezitose, melibiose, raffinose, or sorbitol. The major end product of glucose and/or maltose metabolism is acetate. Esculin and gelatin are not hydrolyzed. Nitrate is not reduced to nitrite. Acetoin is not produced. The cell wall murein type is type A5a (L-Lys-L-Ala-Lys-D-Glu or L-L~s-L~s-D-G~u). The major long-chain CFA are straight-chain saturated and monounsaturated fatty acids. The DNA base composition ranges from 55 to 57 mol% G+C. The type species of the genus is Actinobaculum suis. The genus Actinobaculum is a member of the high-G+ C-content branch of the gram-positive bacteria, in which it forms a distinct phylogenetic lineage. The closest phylogenetic relative of the genus Actinobaculum is the genus Arcanobacterium.
Description of Actinobaculum suis (Wegienek and Reddy) comb. nov. Actinobaculum suis (Eubacterium suis Wegienek and Reddy 1982; "Colynebacterium suis" Soltys and Spratling 1957) (su'is. L. gen. n. suis, of a hog). The description below is based on that given in reference 13. Slender, nonmotile, pleomorphic rods that are 1 to 3 by 0.5 pm and are arranged singly, in pairs (cells are often at an angle to each other or in palisades), or in small clusters. Gram positive, but rather easily decolorized, especially in old cultures. Not acid fast and nonsporulating; does not survive heating at 80°C for 10 min. Capsules are not observed by capsule staining; however, a fringelike outer coat external to the cell wall is seen in thin-section electron micrographs. Colonies on anaerobic blood agar plates are 0.5 to 3.0 mm in diameter after 48 h, white, circular, and granular and have entire to slightly irregular margins. Colonies often have slightly raised centers, which gives them a fried-egg appearance. After 1 week, colonies are 3 to 5 mm in diameter and flatter. Growth is barely discernible after incubation for 7 days under 6% COz or air. Peptone-yeast extract-starch broth supports excellent growth. The optimal pH is 7 to 8; no growth occurs at pH 5.0 or less. The optimal temperature is 37°C; the temperature range for growth is 30 to 43°C; and no growth occurs at 22 to 23°C. Anaerobic. Metabolism is strictly fermentative. Maltose, starch, and glycogen are fermented. Acetate, ethanol, and formate are the main products from maltose fermentation. Adonitol, amygdalin, arabinose, cellobiose, dulcitol, erythritol, esculin, fructose, galactose, glucose, glycerol, inositol, inulin, lactose, mannitol, mannose, melezitose, melibiose, raffinose, rhamnose, salicin, sorbitol, sucrose, trehalose, lactate, pyruvate, and threonine are not fermented. Strongly bernardiae Arcanobacterium haemolyticum Arcanobacterium pyogenes Arcanobacterium phocae
Data from references 4 through 7, 9, 10, 13, and 14.
- Description of Actinobaculum schaalii sp. nov. Actinobaculum schaalii (N. L. gen. n. schaalii, of Schaal, to honor Klaus P. Schaal, contemporary German microbiologist, for his contributions to actinomycete microbiology). Cells are straight to slightly curved rods, some of which exhibit branching. Cells are gram positive, not acid fast, and nonmotile and do not form spores. Nonhemolytic. A weak CAMP reaction occurs. Facultatively anaerobic and catalase negative. Acetate and succinate are the major end products of glucose fermentation. Acid is produced from glucose, maltose, ribose, and D-xylose. Some strains produce acid from L-arabinose, mannose, starch, sucrose, and trehalose. Acid is not produced from D-arabitol, N-acetyl-P-glucosamine, cyclodextrin, glycogen, lactose, mannitol, melezitose, melibiose, methyl-P-D-glucopyranoside, pullulan, rafiinose, sorbitol, and D-tagatose. Hippurate is hydrolyzed. Esculin, gelatin, and urea are not hydrolyzed. a-Glucosidase, alanine-phenylalanine-proline arylamidase, and pyroglutamic acid arylamidase are produced. Alkaline phosphatase, arginine dihydrolase, a-galactosidase, P-galactosidase, P-glucuronidase, glycyl-tryptophan arylamidase, and P-mannosidase activities are not detected. Pyrazinamidase and pyrrolidonylarylamidase activities are shown by some strains. Nitrate is not reduced to nitrite. Acetoin is not produced. The cell wall murein type is type A5a (L-L~s-L~s-D-G~u). The major cellular fatty acids are hexadecanoic, octadecanoic, and cis-delta-9-octadecenoic acids. The DNA base composition is 57 mol% G+C. Strains have been isolated from human blood and urine. The habitat is unknown but is probably the genital or urinary tract. The type strain of Actinobaculum schaalii is CCUG 27420. The source of CCUG 27420T was human blood (chronic pyelonephritis, 64-year-old male). The type strain has the characteristics of the species.
Nucleotide sequence accession number. The 16s rRNA gene sequence of strain CCUG 27420T has been deposited in the GenBank database under accession number Y 12329.
